$SYK

AI Analysis

Generated on May 18, 2026

AI Score
76/ 100
Buy$SYK

Stryker Corporation

$SYKNYSEHealthcareLarge-Cap

Stryker operates as a medical technology company offering orthopedic implants, surgical equipment, and neurotechnology products worldwide.

Market Cap
$145B
Revenue (TTM)
$22.5B
+10.5%
Net Income (TTM)
$4.2B
+14.5%
EPS (TTM)
$11.25
P/E Ratio
34.2
Dividend Yield
0.9%
52-Week Range
$325-$415
Beta
0.92
Dimension Scores
Fundamental
80
Technical
72
Sentiment
76
Risk / Reward
76
Momentum
72
FundTechSentRiskMome
Financial Health
Profitability
80strong
Growth
78moderate
Liquidity
78moderate
Solvency
75moderate
Efficiency
78moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $SYK

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.